|
| 34625984 | Methionine synthase deficiency: Variable clinical presentation and benefit of early diagnosis and treatment. | J Inherit Metab Dis | 2022 |
| 35677112 | Outcomes and genotype correlations in patients with mitochondrial trifunctional protein or isolated long chain 3-hydroxyacyl-CoA dehydrogenase deficiency enrolled in the IBEM-IS database. | Mol Genet Metab Rep | 2022 |
| 35692825 | Using Long-Term Follow-Up Data to Classify Genetic Variants in Newborn Screened Conditions. | Front Genet | 2022 |
| 34905296 | Rare presentation of FDX2-related disorder and untargeted global metabolomics findings. | Am J Med Genet A | 2022 |
| 33388234 | Glycerol phenylbutyrate efficacy and safety from an open label study in pediatric patients under 2Â months of age with urea cycle disorders. | Mol Genet Metab | 2021 |
| 33729671 | Cobalamin J disease detected on newborn screening: Novel variant and normal neurodevelopmental course. | Am J Med Genet A | 2021 |
| 33372121 | Management Principles for Acute Illness in Patients With Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency. | Pediatrics | 2021 |
| 33241662 | Mary Ella Mascia Pierpont: Geneticist, scientist, mentor, friend (1945-2020). | Am J Med Genet A | 2021 |
| 33443292 | Liver transplant as a curative treatment in a pediatric patient with classic homocystinuria: A case report. | Am J Med Genet A | 2021 |
| 31337884 | Developing interactions with industry in rare diseases: lessons learned and continuing challenges. | Genet Med | 2020 |
| 32034080 | Medical Foods for Inborn Errors of Metabolism: History, Current Status, and Critical Need. | Pediatrics | 2020 |
| 32741966 | Treatment of mucopolysaccharidosis type II (Hunter syndrome): a Delphi derived practice resource of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2020 |
| 32685345 | PMM2-CDG caused by uniparental disomy: Case report and literature review. | JIMD Rep | 2020 |
| 32342790 | Integrating Rules for Genomic Research, Clinical Care, Public Health Screening and DTC Testing: Creating Translational Law for Translational Genomics. | J Law Med Ethics | 2020 |
| 30393376 | Foundation of the Newborn Screening Translational Research Network and its tools for research. | Genet Med | 2019 |
| 32076389 | Endothelial dysfunction in a child with Pearson marrow-pancreas syndrome managed with Descemet stripping automated endothelial keratoplasty using a suture pull-through technique. | Digit J Ophthalmol | 2019 |
| 30100612 | Including ELSI research questions in newborn screening pilot studies. | Genet Med | 2019 |
| 31326288 | Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients. | Mol Genet Metab | 2019 |
| 31566897 | Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome. | Am J Med Genet A | 2019 |
| 31074578 | A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy. | Am J Med Genet A | 2019 |
| 31160753 | Improving recommendations for genomic medicine: building an evolutionary process from clinical practice advisory documents to guidelines. | Genet Med | 2019 |
| 30549415 | An N-terminal heterozygous missense CASK mutation is associated with microcephaly and bilateral retinal dystrophy plus optic nerve atrophy. | Am J Med Genet A | 2019 |
| 29304374 | Biallelic Mutations in FUT8 Cause a Congenital Disorder of Glycosylation with Defective Fucosylation. | Am J Hum Genet | 2018 |
| 30217721 | Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2⿯months to 2⿯years of age with urea cycle disorders. | Mol Genet Metab | 2018 |
| 29914349 | Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1. | J Neurodev Disord | 2018 |
| 29928179 | Necrotizing Enterocolitis in Two Siblings and an Unrelated Infant with Overlapping Chromosome 6q25 Deletions. | Mol Syndromol | 2018 |
| 30008546 | Pragmatic Tools for Sharing Genomic Research Results with the Relatives of Living and Deceased Research Participants. | J Law Med Ethics | 2018 |
| 29463858 | Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9. | Eur J Hum Genet | 2018 |
| 27776753 | Comparison of Methods of Initial Ascertainment in 58 Cases of Propionic Acidemia Enrolled in the Inborn Errors of Metabolism Information System Reveals Significant Differences in Time to Evaluation and Symptoms at Presentation. | J Pediatr | 2017 |
| 28451876 | An Exploration of Genetic Test Utilization, Genetic Counseling, and Consanguinity within the Inborn Errors of Metabolism Collaborative (IBEMC). | J Genet Couns | 2017 |
| 28916119 | Safety and efficacy of glycerol phenylbutyrate for management of urea cycle disorders in patients aged 2months to 2years. | Mol Genet Metab | 2017 |
| 25856670 | Outcomes of four patients with homocysteine remethylation disorders detected by newborn screening. | Genet Med | 2016 |
| 26586473 | Glutamine and hyperammonemic crises in patients with urea cycle disorders. | Mol Genet Metab | 2016 |
| 27477829 | 221 newborn-screened neonates with medium-chain acyl-coenzyme A dehydrogenase deficiency: Findings from the Inborn Errors of Metabolism Collaborative. | Mol Genet Metab | 2016 |
| 27268406 | A framework for assessing outcomes from newborn screening: on the road to measuring its promise. | Mol Genet Metab | 2016 |
| 27195819 | Inborn Errors of Metabolism Collaborative: large-scale collection of data on long-term follow-up for newborn-screened conditions. | Genet Med | 2016 |
| 27209629 | Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database. | Mol Genet Metab | 2016 |
| 27033733 | Outcomes of cases with 3-methylcrotonyl-CoA carboxylase (3-MCC) deficiency - Report from the Inborn Errors of Metabolism Information System. | Mol Genet Metab | 2016 |
| 25957469 | Autosomal-Dominant Multiple Pterygium Syndrome Is Caused by Mutations in MYH3. | Am J Hum Genet | 2015 |
| 28649536 | Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate. | Mol Genet Metab Rep | 2015 |
| 26296711 | Self-reported treatment-associated symptoms among patients with urea cycle disorders participating in glycerol phenylbutyrate clinical trials. | Mol Genet Metab | 2015 |
| 26479555 | Returning a Research Participant's Genomic Results to Relatives: Analysis and Recommendations. | J Law Med Ethics | 2015 |
| 26499378 | Lack of IL7Rα expression in T cells is a hallmark of T-cell immunodeficiency in Schimke immuno-osseous dysplasia (SIOD). | Clin Immunol | 2015 |
| 26364901 | Report of a patient with a constitutional missense mutation in SMARCB1, Coffin-Siris phenotype, and schwannomatosis. | Am J Med Genet A | 2015 |
| 26042913 | Newborn screening. | Clin Perinatol | 2015 |
| 24385074 | Phenylalanine hydroxylase deficiency: diagnosis and management guideline. | Genet Med | 2014 |
| 24630270 | Glycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes. | Mol Genet Metab | 2014 |
| 24394680 | Parental permission for pilot newborn screening research: guidelines from the NBSTRN. | Pediatrics | 2014 |
| 22961727 | Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate. | Hepatology | 2013 |
| 24144944 | Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio. | Mol Genet Metab | 2013 |